WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

XI'AN CITY, SHAANXI PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- The global nootropics and wellness ...

This allows brands to develop breakthrough hair serums more quickly and more consistently across global markets. Industry ...

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc., a global clinical-stage biotechnology company advancing next-generation ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...

OYE Therapeutics has been authorized to initiate clinical development of its OYE-101 caffeine injection after the U.S. FDA cleared its Investigational New Drug applications. OYE-101 is a novel ...

PPG Industries, Inc. is rated a Buy with strong BBB+ balance sheet, 53-year dividend growth streak and active buybacks. Read ...

The Ministry of Planning, Economic Development and International Cooperation has issued its 2025 Annual Report—for the sixth consecutive year—under the title “Jobs, Growth and Resilience: Delivering ...

Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.

Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.

VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases ...